Bee House
140 Eastern Avenue Milton Park
Oxford OX14 4SB
United Kingdom
44 123 5841575
https://www.physiomics.co.uk
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 10
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Christophe D. Chassagnole Ph.D. | Chief Scientific Officer & Executive Director | 87.48k | N/A | 1970 |
Dr. Peter Joseph Sargent | CEO, COO & Director | N/A | N/A | 1978 |
Prof. David Fell | Co-Founder & Member of Scientific Advisory Board | N/A | N/A | N/A |
Mr. Anthony Louis Clayden ACA, BSc (Hons), MSI | Head of Finance & Company Secretary | N/A | N/A | 1968 |
Ms. Hayley Close | Head of Business Development | N/A | N/A | N/A |
Dr. Venkata Putcha | Head of Biostatistics | N/A | N/A | N/A |
Dr. Mark Middleton M.D., Ph.D. | Consultant & Member of Scientific Advisory Board | N/A | N/A | N/A |
Dr. Robert Jackson Ph.D. | Consultant & Member of Scientific Advisory Board | N/A | N/A | 1944 |
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Physiomics Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.